首页 | 本学科首页   官方微博 | 高级检索  
检索        

负荷剂量氯吡格雷治疗进展性脑卒中的临床研究
引用本文:陈汉波,彭卓惠,谢文燕,黄斌,杨湘伟.负荷剂量氯吡格雷治疗进展性脑卒中的临床研究[J].中华临床医师杂志(电子版),2013,7(9):3724-3727.
作者姓名:陈汉波  彭卓惠  谢文燕  黄斌  杨湘伟
作者单位:陈汉波 (潮州市中心医院神经内科,广东省,521000); 彭卓惠 (潮州市中心医院神经内科,广东省,521000); 谢文燕 (潮州市中心医院神经内科,广东省,521000); 黄斌 (潮州市中心医院神经内科,广东省,521000); 杨湘伟 (潮州市中心医院神经内科,广东省,521000);
摘    要:目的通过本研究探索负荷剂量氯吡格雷治疗进展性脑卒中的I临床疗效及安全性。方法对发病48h内入院120例进展性脑卒中患者随机分为治疗组和对照组,治疗组应用负荷剂量氯吡格雷治疗(首次300mg,以后75mg/d),对照组应用标准剂量氯吡格雷治疗(75mg/d),两组连用14d。两组患者基础治疗相同,有脑水肿者适当应用甘露醇脱水治疗。治疗前、治疗后72h、第7天、第14天分别进行美国国立卫生研究院卒中量表(NIHSS)评分和Barthel指数(BI)评定,并于随访3个月时再评估。检测治疗前后血小板计数、凝血酶原时间及纤维蛋白原水平。用药第8天复查头颅CT或MRI,观察梗死灶面积是否扩大或出血。结果治疗后72h、7d、14d,治疗组的NIHSS评分显著低于对照组(P〈0.01)。血小板计数、凝血酶原时间、纤维蛋白原水平治疗前后比较差异无统计学意义(P〉0.05)。复查头颅CT或MRI,治疗组有1例梗死灶出现点状出血,对照组未见脑出血;两组各1例皮疹;不良反应无统计学意义。完成3个月随访者98例,治疗组50例,BI≥75者35例(70.0%),有效率≥18%者40例(80.0%);对照组48例,BI≥75者19例(39.6%),有效率≥18%者21例(43.8%)。治疗组BI≥75者比例明显高于对照组(P〈0.01),治疗组有效率较对照组明显升高(P〈0.01)。结论早期应用负荷剂量氯吡格雷明显较标准氯吡格雷更能防治缺血性脑卒中的进展,提高疗效,改善预后,未发现安全问题,值得进一步研究。

关 键 词:卒中  负荷剂量  氯吡格雷

Clinical study of loading dose of Clopidogrel in the treatment of progressive stroke
Institution:CHEN Han-bo ,PENG Zhuo-hui ,XIE Wen-yah, HUAN G Bin, YAN G Xiang-wei( Department of Neurology, the Central Hospital of Chaozhou , Chaozhou 521000, China)
Abstract:Objective To explore the clinical efficacy and safety of loading dose of Clopidogrel in the treatment of progressive stroke. Methods One hundred and twenty eases of progressive stroke patients who hospitalized within 48 h of falling ill were randomly divided into treatment group and control group. The treatment group were treated with loading dose of Clopidogrel (first 300 mg, after 75 mg/d)for 14 d. The control group were treated with standard dose of clopidogrel(75 mg/d)for 14 d. The basic treatment of the two groups, who had cerebral edema accapted mannitol therapy, was same. The two groups were scored by the NIH Stroke Scale (NIHSS) and Barthel Index(BI) before and after 72 h,7 d, 14 d of treatment, and re-evaluated in the 3-month follow-up. Platelet count, prothrombin time, and fibrinogen levels were detected before and after treatment. The two groups were reviewed by head CT or MRI in the eighth day to observe whether the infarction proportion expanding or bleeding. Results NIHSS scores of the treatment group were significantly lower than that in the control group after the treamtent of 72 h,7 d, 14 d ( P 〈 0. 01 ). The levels of platelet count, prothrombin time and fibrinogen before and after treatment had no significant difference ( P 〉 0.05 ). One ease of the treatment group had spotting in the infarction, and no one of the control group had cerebral hemorrhage. Each one of the two groups had rash. The adverse reactions of the two groups was not significant. There were 98 patients completed the 3-month follow-up in the two groups. Treatment group included 50 patients, in which 35 (70. 0% )patients' BI were greater than or equal to 75, and 40 (80. 0% )patients' efficiency were greater than or equal to 18%. Control group included 48 patients, in which 19 (39. 6% )patients' BI were greater than or equal to 75, and 21 (43. 8% )patients' efficiency were greater than or equal to 18%. The proportion of BI greater than or equal to 75 of the treatment group was significantly higher than that of the control group (P 〈 0.01 ), and the efficiency of the treatment group was significantly higher than that of the control group( P 〈 0.01 ). Conclusion It is more effective to prevent the progress of ischemic stroke with loading dose of clopidogrel than standard dose of clopidogrel in the early treatment of progressive stroke, and it also can improve efficacy and prognosis. This method is found no safety issues and worth further study.
Keywords:Stroke  Loading dose  Clopidogrel
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号